Tyler Van Buren

Managing Director, Health Care - Biotechnology

Headshot photo of Tyler Van Buren

Tyler Van Buren is a Managing Director and senior equity research analyst on the biotechnology team at Cowen. Mr. Van Buren has over a decade of equity research experience and is responsible for providing analysis on large-, mid-, and small-cap biotechnology stocks.

Prior to rejoining Cowen, Mr. Van Buren was a Managing Director and senior biotechnology equity research analyst at Piper Sandler (previously Piper Jaffray) for over three years. Prior to Piper Sandler, Mr. Van Buren spent five years on the biopharma research team at Cowen. Previously, Van Buren was a founding member and Managing Director at LifeSci Advisors where he helped build the firm’s biotechnology research practice. Earlier in his career, he worked at Amylin Pharmaceuticals, Lithera Pharmaceuticals, the Sanford-Burnham Medical Research Institute, and the U.S. Department of Agriculture.

Mr. Van Buren earned a master’s degree in biology and a bachelor’s degree in biochemistry and cellular biology from the University of California, San Diego.


Get In Touch

Start a conversation with Tyler Van Buren


    Explore related thought leadership, reports, coverage and insights for Tyler Van Buren.

    Best ESG Investment Ideas for 2023

    Ahead of the Curve®

    A Primer On The Next Generation Of Radiopharmaceuticals

    A variety of pharmaceuticals laid on top of a desk next to a calculator, representing our drug pricing outlook. Laid on top are a variety of pills of various colors.
    Ahead of the Curve®

    The Price Is (Not) Right: Discounts, 340B, Access, And IRA